diabetes

COLLEGE STATION, Texas, July 6, 2026 Matica Biotechnology, Inc. (Matica Bio) has entered into a strategic partnership with VaxDome...

NEW YORK, July 6, 2026 DarioHealth Corp. has announced a significant expansion of its digital health platform through a...

NEW YORK, June 30, 2026 Renalytix PLC has announced the publication of groundbreaking two-year real-world evidence (RWE) demonstrating that...

BAGSVÆRD, Denmark, May 22, 2026 Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal Products for Human...

BAGSVAERD, Denmark, May 12, 2026 Novo Nordisk announced new clinical findings at the 2026 European Congress on Obesity (ECO...

RUTHERFORD, N.J., May 7, 2026 Glucotrack, Inc. announced the submission of an Investigational Device Exemption (IDE) application to the...

Toronto, Canada | May 1, 2026 Apotex has received Health Canada approval for Apo-Semaglutide Injection™, a generic equivalent of...

Hong Kong | April 27, 2026 Ascletis Pharma Inc. has announced the successful completion of enrollment in its U.S....

INDIANAPOLIS, April 9, 2026 Eli Lilly and Company has announced the U.S. launch of Foundayo™ (orforglipron), a first-in-class oral...

MUMBAI, INDIA, March 21, 2026 Sun Pharmaceutical Industries Limited has announced the launch of its semaglutide injection under the...